St Teresa Medical
Woodbury, US · Founded 2010 · Minnesota corporation
Find your way into St Teresa Medical
Sign up to see every warm intro you have to St Teresa Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the St Teresa Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
St Teresa Medical develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications, derived from battlefield trauma treatment technology. The company targets the hemostatic and therapeutic markets with fibers designed to control bleeding and support wound healing during surgery.
Founders & leadership
PA
PHILIP A. MESSINAExecutive
BJ
BRIAN JACKSONExecutive
CT
Charles Timothy Floyd MDExecutive
PA
PHILLIP A. MESSINAExecutive
DF
Dan FisherExecutive
AT

Andrew T. RockChief Executive Officer & Chairman of the BoardAndrew T. Rock is CEO and Chairman of St Teresa Medical, which develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications. He has held roles in sales and leadership across the medical technology sector, co-founded K2M Group (acquired by Stryker), and holds over 18 patents related to spine treatment.
MP

Michael ParkmanVice President of Sales
Board
LG
LAWRENCE G. SUCSYBoard director
Reported raises · per SEC filings
Form D private placements$16.8M disclosed across 7 rounds · 2014–2019
▶$2MraisedAug 2019 · 15 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2019 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas DelaneyDirector
- Bradley PaddockDirector
- Brian JacksonExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $2M
- Placement agents
- Commenda Securities LLC
- First sale
- Apr 2019
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$5MraisedDec 2018 · 63 investors · Other Health CareRule 506(b)
▶$5MraisedDec 2018 · 63 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian JacksonExecutive Officer, Director
- Alex Powers, M.D.Director
- Philip MessinaExecutive Officer, Director
- Andrew RockExecutive Officer, Director
- Offering amount
- $6.8M
- Amount sold
- $5M
- First sale
- Sep 2018
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$100KraisedAug 2017 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedAug 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- LAWRENCE G. SUCSYDirector
- ANDY ROCKDirector
- ALEXANDROS POWERSDirector
- BRIAN J. JACKSONExecutive Officer, Director
- PHILIP A. MESSINAExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $100K
- Minimum investment
- $50K
- Sales commissions
- $6K
- Placement agents
- SF INVESTMENTS, INC.
- First sale
- Aug 2017
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$270KraisedMar 2016 · 4 investors · Other Health CareRule 506(b)
▶$270KraisedMar 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- BRIAN JACKSONExecutive Officer, Director
- PHILIP MESSINAExecutive Officer, Director
- LAWRENCE SUCSYDirector
- Offering amount
- $750K
- Amount sold
- $270K
- First sale
- Jan 2016
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$6.2MraisedOct 2015 · 38 investors · Other Health CareRule 506(b)
▶$6.2MraisedOct 2015 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- LAWRENCE G. SUCSYDirector
- PHILIP A. MESSINAExecutive Officer, Director
- BRIAN JACKSONExecutive Officer, Director
- Offering amount
- $6.2M
- Amount sold
- $6.2M
- Minimum investment
- $50K
- Sales commissions
- $350K
- Placement agents
- SF INVESTMENTS, INC.
- First sale
- May 2015
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$2.1MraisedMay 2015 · 7 investors · Other Health CareRule 506(b)
▶$2.1MraisedMay 2015 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- BRIAN J. JACKSONExecutive Officer, Director
- PHILLIP A. MESSINAExecutive Officer, Director
- LAWRENCE SUCSYDirector
- Offering amount
- $5M
- Amount sold
- $2.1M
- Minimum investment
- $50K
- Sales commissions
- $350K
- Placement agents
- SF INVESTMENTS
- First sale
- May 2015
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$1.1MraisedMar 2014 · 3 investors · Other Health CareRule 506(b)
▶$1.1MraisedMar 2014 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- BRIAN J. JACKSONExecutive Officer, Director
- Charles Timothy Floyd MDExecutive Officer
- PHILLIP A. MESSINAExecutive Officer, Director
- Dan FisherExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- Sales commissions
- $75K
- Finders' fees
- $210K
- Placement agents
- SF Investments, Inc.
- First sale
- Feb 2014
- Incorporated
- Corporation, Minnesota, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
SharecareSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies working in the same space as St Teresa Medical.
Frequently asked questions
- What does St Teresa Medical do?
- St Teresa Medical develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications, derived from battlefield trauma treatment technology. The company targets the hemostatic and therapeutic markets with fibers designed to control bleeding and support wound healing during surgery.
- How much funding has St Teresa Medical raised?
- St Teresa Medical has disclosed $16.8M raised across 7 rounds.
- Where is St Teresa Medical headquartered?
- St Teresa Medical is headquartered in Woodbury, US.

